Use of ipratropium bromide in asthma. Results of a multi-clinic study.
暂无分享,去创建一个
W. Busse | R. Nathan | C. Falliers | R. Bush | J. G. Weg | W. Storms | S. Bodman | C. Falliers | J. D. O'Hollaren | J. Weg | J. D. O'HOLLAREN
[1] I. Cameron,et al. Bronchoconstriction in response to suggestion: its prevention by an inhaled anticholinergic agent. , 1985, British medical journal.
[2] N. Gross,et al. Anticholinergic, antimuscarinic bronchodilators. , 2015, The American review of respiratory disease.
[3] Rebuck As,et al. SCH 1000 in psychogenic asthma. , 1979 .
[4] J. Molkenboer,et al. The effect of Atrovent in micturition function, double blind cross-over study. , 1979, Scandinavian journal of respiratory diseases. Supplementum.
[5] I. Lightbody,et al. Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis. , 1978, British journal of diseases of the chest.
[6] D. Cockcroft,et al. A comparison of the protective effect of fenoterol and Sch 1000 on allergen-induced asthma. , 1978, The Journal of allergy and clinical immunology.
[7] R. Townley,et al. Comparison of the bronchodilating effects of SCH 1000 with isoproterenol in patients with bronchial asthma. , 1976, Annals of allergy.
[8] G. Dopico,et al. Aerosol Sch 1000. An anticholinergic bronchodilator. , 1975, The American review of respiratory disease.
[9] E. Thompson,et al. Methoxy-9-ellipticine lactate in refractory acute myeloid leukaemia , 1975, Postgraduate medical journal.
[10] B. Gandevia. Historical review of the use of parasympatholytic agents in the treatment of respiratory disorders. , 1975, Postgraduate medical journal.